Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,138.10 +100.88 0.67%
Hang Seng 23,082.70 +38.44 0.17%
S&P/ASX 200 5,180.77 +15.11 0.29%
  • Fund Type: ETN
  • Objective: Sector Fund-Undefined Equity
  • Asset Class: Equity
  • Geographic Focus: Global

RBS Global Big Pharma ETNs

+ Add to Watchlist

DRGS:US

34.6351 USD 0.0351 0.10%

As of 20:04:03 ET on 05/17/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for RBS Global Big Pharma ETNs (DRGS)

Open: 34.6351 High - Low: 34.6351 - 34.6351 Primary Exchange: NYSE Arca
Volume: 200 52-Week Range: 26.0800 - 35.2700 Beta vs DGETR: -

ETF Chart for DRGS

No chart data available.
  • DRGS:US 34.6351
  • 1D
  • 1M
  • 1Y
34.6000
Interactive DRGS Chart

Previous Close

Fund Profile & Information for DRGS

RBS Global Big Pharma ETN is an exchange-traded note issued in the USA. The ETN is designed to track the performance of the NYSE Arca Equal Weighted Pharmaceutical Total Return Index.

Inception Date: 2011-10-21 Telephone: 1-855-RBS-ETPS
Managers: -
Web Site: usmarkets.rbs.com/etnUS

Fundamentals for DRGS

NAV (on 2013-05-17) 34.6216
Assets (M) (on 2013-02-28) 5.0698
Shares out (M) 0.16
Market Cap (M) 5.54
% Premium 0.04
Average 52-Week % Premium -0.0073
Fund Leveraged N

Dividends for DRGS

No dividends reported

Performance for DRGS

1-Month +2.11% 1-Year +29.14%
3-Month +9.03% 3-Year -
Year To Date +17.13% 5-Year -
Expense Ratio 0.60

Top Fund Holdings for DRGS

Holding Data Unavailable.

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil